Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.28USD
7:16pm GMT
Change (% chg)

$0.01 (+3.77%)
Prev Close
$0.26
Open
$0.28
Day's High
$0.28
Day's Low
$0.25
Volume
51,995
Avg. Vol
45,821
52-wk High
$2.56
52-wk Low
$0.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.632
Jun '18 0.00 -0.378
Mar '18 0.00 -0.266
FY 2017 Dec '17 0.00 -0.139
Sep '17 0.00 -0.603
Sep '17 0.00 -0.075
Dec 0.00 -0.600
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-19 1 -0.64 -0.64 -0.64 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 1.54 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 5.85 10.14 5.26
Price to Tangible Book (MRQ) 12.10 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 9.99 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 117.49 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 53.86 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 4.48 3.50 3.08
LT Debt to Equity (MRQ) 0.00 18.65 11.38
Total Debt to Equity (MRQ) 0.00 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.45 12.86
Operating Margin (TTM) -- -184.67 6.20
Operating Margin - 5 Yr. Avg. -- -126.94 8.31
Pre-Tax Margin (TTM) -- -175.36 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.73 8.61
Net Profit Margin (TTM) -- -182.07 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.12 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,654,354 842,397,297
Net Income/Employee (TTM) -- 562,076 99,842,671
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.57 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -126.93 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -- 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 59.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ContraVir Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 22.24 18.02 99 99
13 Week 10.71 5.32 99 95
26 Week -61.25 -64.20 12 98
52 Week -45.61 -53.90 41 72
YTD -48.33 -54.63 24 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.46%
# of Holders: 24
Total Shares Held: 739,518
3 Mo. Net Change: 26,328
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.